Literature DB >> 20135938

The association of race and survival from sepsis after injury.

David S Plurad1, Thomas Lustenberger, Patrick Kilday, Jay Zhu, Donald J Green, Kenji Inaba, Peep Talving, Howard Belzberg, Demetrios Demetriades.   

Abstract

Genetic variation is associated with outcome disparity in critical illness. We sought to determine if race is independently associated with the development of posttraumatic sepsis and subsequent related mortality. Our Intensive Care Unit database was queried for admissions from January 1, 2000 to June 30, 2007. Patients were prospectively followed for sepsis (Any four of the following symptoms: temperature > or =38 degrees C, heart rate (HR) > or =90 b/m, RR > or =20 b/m (or PaCO2 < or =32 mm Hg), white blood cell count (WBC) > or =12, or vasopressor requirement all with an infectious source). White, Black, Hispanic, and Asian groups were defined. "Other" race was excluded. Most of the 3998 study patients were male (3157, 79.0%). Blunt trauma (2661, 66.6%) predominated. Six-hundred-seventy-seven (16.9%) met sepsis criteria. Mortality was 14.0 per cent (560). Sepsis was increased in Asians versus all others combined (23.7% vs. 16.1%). Race was independently associated with sepsis (adjusted odds ratio (OR) 1.12 (1.01-1.24), P value = 0.03). Sepsis associated mortality was 36.9 per cent (250/677). Black race demonstrated an increased survival versus all others after sepsis (25.4% vs. 37.7%) but this was not statistically significant (adjusted OR 0.96 (0.73-1.18), P value = 0.71). Race is independently associated with posttraumatic sepsis and possibly subsequent sepsis associated mortality. Further related study is needed with the ultimate goal of genetically based treatments for the prevention and treatment of sepsis after injury.

Entities:  

Mesh:

Year:  2010        PMID: 20135938

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  7 in total

Review 1.  Hispanic mortality paradox: a systematic review and meta-analysis of the longitudinal literature.

Authors:  John M Ruiz; Patrick Steffen; Timothy B Smith
Journal:  Am J Public Health       Date:  2013-01-17       Impact factor: 9.308

2.  Health Disparities and Sepsis: a Systematic Review and Meta-Analysis on the Influence of Race on Sepsis-Related Mortality.

Authors:  Panagis Galiatsatos; Junfeng Sun; Judith Welsh; Anthony Suffredini
Journal:  J Racial Ethn Health Disparities       Date:  2019-05-29

3.  Cardiovascular Events and Hospital Deaths Among Patients With Severe Sepsis.

Authors:  Nirav Patel; Navkaranbir S Bajaj; Rajkumar Doshi; Ankur Gupta; Rajat Kalra; Amitoj Singh; Lorenzo Berra; Garima Arora; Sumanth D Prabhu; Pankaj Arora
Journal:  Am J Cardiol       Date:  2019-02-07       Impact factor: 2.778

4.  An anticomplement agent that homes to the damaged brain and promotes recovery after traumatic brain injury in mice.

Authors:  Marieta M Ruseva; Valeria Ramaglia; B Paul Morgan; Claire L Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

5.  Methodological challenges in European ethics approvals for a genetic epidemiology study in critically ill patients: the GenOSept experience.

Authors:  Ascanio Tridente; Paul A H Holloway; Paula Hutton; Anthony C Gordon; Gary H Mills; Geraldine M Clarke; Jean-Daniel Chiche; Frank Stuber; Christopher Garrard; Charles Hinds; Julian Bion
Journal:  BMC Med Ethics       Date:  2019-05-07       Impact factor: 2.652

6.  Incidence, Risk Factors, and Management of Infection Following Anterior Cruciate Ligament Reconstruction Surgery.

Authors:  Ravi Gupta; Munish Sood; Anubhav Malhotra; Gladson David Masih; Mukta Raghav; Tanu Khanna
Journal:  Indian J Orthop       Date:  2018 Jul-Aug       Impact factor: 1.251

7.  The prognostic value of serum procalcitonin measurements in critically injured patients: a systematic review.

Authors:  Aziza N AlRawahi; Fatma A AlHinai; Christopher J Doig; Chad G Ball; Elijah Dixon; Zhengwen Xiao; Andrew W Kirkpatrick
Journal:  Crit Care       Date:  2019-12-03       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.